Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Junji Shiode is active.

Publication


Featured researches published by Junji Shiode.


Digestive Endoscopy | 2010

ADVANTAGES OF USING THIN ENDOSCOPE‐ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION TECHNIQUE FOR LARGE COLORECTAL TUMORS

Toshio Uraoka; Shin Ishikawa; Jun Kato; Reiji Higashi; Hideyuki Suzuki; Eisuke Kaji; Motoaki Kuriyama; Shunsuke Saito; Mitsuhiro Akita; Keisuke Hori; Keita Harada; Shuhei Ishiyama; Junji Shiode; Yoshiro Kawahara; Kazuhide Yamamoto

Background:  Our purpose was to evaluate the effectiveness of a newly developed non‐invasive traction technique known as thin endoscope‐assisted endoscopic submucosal dissection (TEA‐ESD) procedure for the removal of colorectal laterally spreading tumors (LST).


Diseases of The Colon & Rectum | 2006

Risk Factors and Indications for Colectomy in Ulcerative Colitis Patients are Different According to Patient’s Clinical Background

Motoaki Kuriyama; Jun Kato; Tsuyoshi Fujimoto; Junichirou Nasu; Jiro Miyaike; Takechiyo Morita; Hiroyuki Okada; Seiyuu Suzuki; Junji Shiode; Hiroshi Yamamoto; Yasushi Shiratori

PurposeDespite progress in medical treatment for ulcerative colitis, a considerable fraction of ulcerative colitis patients undergo colectomy. We analyzed the clinical variables of ulcerative colitis patients and determined the risk factors and indications for colectomy.MethodsThe clinical records of 981 consecutive Japanese patients with ulcerative colitis were reviewed both retrospectively and prospectively.ResultsOf 981 patients with ulcerative colitis, 85 patients underwent colectomy. Multivariate analysis indicated that male gender (risk ratio, 2.16; 95 percent confidence interval, 1.37–3.42), onset year during and after 2000 (risk ratio, 2.85; 95 percent confidence interval, 1.31–6.22), severe disease activity (risk ratio, 2; 95 percent confidence interval, 1.15–3.48), corticosteroid resistance (risk ratio, 7.05; 95 percent confidence interval, 4.29–11.59), and complications because of corticosteroid administration (risk ratio, 3.55; 95 percent confidence interval, 2.08–6.06) were significant risk factors for colectomy. In patients with disease duration of more than five years, only corticosteroid resistance and complications because of corticosteroid were significant risk factors for colectomy. When we stratified indications for colectomy for the 85 cases via patient disease duration, massive hemorrhage was a relatively frequent cause of colectomy in patients with a disease duration of less than five years (P = 0.091). On the other hand, colon dysplasia or cancer was a major cause for colectomy in patients with a disease duration of more than ten years (P = 0.0001).ConclusionsIn ulcerative colitis patients, the risk factors and indications for colectomy were different according to the patients clinical background. Our findings may help to predict patients with ulcerative colitis who have a high risk for colectomy.


World Journal of Gastroenterology | 2012

Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement

Masaya Iwamuro; Hiroyuki Okada; Katsuyoshi Takata; Katsuji Shinagawa; Shigeatsu Fujiki; Junji Shiode; Atsushi Imagawa; Masashi Araki; Toshiaki Morito; Mamoru Nishimura; Motowo Mizuno; Tomoki Inaba; Seiyu Suzuki; Yoshinari Kawai; Tadashi Yoshino; Yoshiro Kawahara; Akinobu Takaki; Kazuhide Yamamoto

AIM To investigate the capacity for 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) to evaluate patients with gastrointestinal lesions of follicular lymphoma. METHODS This retrospective case series consisted of 41 patients with follicular lymphoma and gastrointestinal involvement who underwent 18F-FDG-PET and endoscopic evaluations at ten different institutions between November 1996 and October 2011. Data for endoscopic, radiological, and biological examinations performed were retrospectively reviewed from clinical records. A semi-quantitative analysis of 18F-FDG uptake was performed for each involved area by calculating the maximum standardized uptake value (SUVmax). Based on the positivity of 18F-FDG uptake in the gastrointestinal lesions analyzed, patients were subdivided into two groups. To identify potential predictive factors for 18F-FDG positivity, these two groups were compared with respect to gender, age at diagnosis of lymphoma, histopathological grade, pattern of follicular dendritic cells, mitotic rate, clinical stage, soluble interleukin-2 receptor levels detected by 18F-FDG-PET, lactate dehydrogenase (LDH) levels, hemoglobin levels, bone marrow involvement, detectability of gastrointestinal lesions by computed tomography (CT) scanning, and follicular lymphoma international prognostic index (FLIPI) risk. RESULTS Involvement of follicular lymphoma in the stomach, duodenum, jejunum, ileum, cecum, colon, and rectum was identified in 1, 34, 6, 3, 2, 3, and 6 patients, respectively. No patient had esophageal involvement. In total, 19/41 (46.3%) patients exhibited true-positive 18F-FDG uptake in the lesions present in their gastrointestinal tract. In contrast, false-negative 18F-FDG uptake was detected in 24 patients (58.5%), while false-positive 18F-FDG uptake was detected in 5 patients (12.2%). In the former case, 2/19 patients had both 18F-FDG-positive lesions and 18F-FDG-negative lesions in the gastrointestinal tract. In patients with 18F-FDG avidity, the SUVmax value of the involved gastrointestinal tract ranged from 2.6 to 17.4 (median: 4.7). For the 18F-FDG-negative (n = 22) and -positive (n = 19) groups, there were no differences in the male to female ratios (10/12 vs 4/15, P = 0.186), patient age (63.6 ± 2.4 years vs 60.1 ± 2.6 years, P = 0.323), presence of histopathological grade 1 vs 2 (20/2 and 17/2, P = 1.000), follicular dendritic cell pattern (duodenal/nodal: 13/5 vs 10/3, P = 1.000), mitotic rate (low/partly high, 14/1 vs 10/3, P = 0.311), clinical stage according to the Ann Arbor system (stages IE and IIE/other, 15/7 vs 15/4, P = 0.499), clinical stage according to the Lugano system (stages I and II-1/other, 14/8 vs 14/5, P = 0.489), soluble interleukin-2 receptor levels (495 ± 78 vs 402 ± 83, P = 0.884), LDH levels (188 ± 7 vs 183 ± 8, P = 0.749), hemoglobin levels (13.5 ± 0.3 vs 12.8 ± 0.4, P = 0.197), bone marrow involvement (positive/negative, 1/8 vs 1/10, P = 1.000), detectability by CT scanning (positive/negative, 1/16 vs 4/13, P = 0.335), and FLIPI risk (low risk/other, 16/6 vs 13/6, P = 0.763), respectively in each case. CONCLUSION These findings indicate that it is not feasible to predict 18F-FDG-avidity. Therefore, 18F-FDG-PET scans represent a complementary modality for the detection of gastrointestinal involvements in follicular lymphoma patients, and surveillance of the entire gastrointestinal tract by endoscopic examinations is required.


European Journal of Gastroenterology & Hepatology | 2008

Risk factors for high-grade dysplasia or carcinoma in colorectal adenoma cases treated with endoscopic polypectomy

Manabu Kurome; Jun Kato; Toru Nawa; Tsuyoshi Fujimoto; Hiroshi Yamamoto; Junji Shiode; Masaki Wato; Kenji Kuwaki; Hiroyuki Okada; Kohsaku Sakaguchi; Yasushi Shiratori

Objective Our aim is to establish the risk factors for carrying high-grade dysplasia or carcinoma by analyzing endoscopically treated adenoma cases. Methods Patients who underwent endoscopic polypectomy at our hospitals between January 2003 and August 2004 were analyzed. Results A total of 889 patients (mean age: 63±11 years), and 1486 adenomas resected from these patients, were included in the analysis. Seventy-five adenomas (5%) from 72 patients (8%) were found to have high-grade dysplasia or carcinoma. Among patient factors, female sex [odds ratio (OR) 2.25, 95% confidence intervals (CI)=1.34–3.76], presence of multiple adenomas (OR=2.15, 95% CI=1.15–4.00), older age (OR=1.02, 95% CI=1.00–1.04), and rectal bleeding as the indication for colonoscopy (OR=2.57, 95% CI=1.34–4.92) were identified as the significant risk factors for carrying high-grade dysplasia or carcinoma using the multivariate analysis. In addition, a size of ≥10 mm (OR=10.83, 95% CI=5.86–20.0), flat appearance (OR=3.91, 95% CI=2.20–6.95), and location on the left side of the colon (OR=1.80, 95% CI=1.03–3.13) were identified as tumor risk factors. Conclusion Distinct factors were proved to be associated with high-grade dysplasia or carcinoma. These results are useful to select lesions that require immediate treatment. Moreover, female sex as a risk factor raises an interesting problem regarding the progression from adenoma to carcinoma.


Internal Medicine | 2014

Clinical Characteristics and Treatment Outcomes of Nineteen Japanese Patients with Gastrointestinal Bezoars

Masaya Iwamuro; Shouichi Tanaka; Junji Shiode; Atsushi Imagawa; Motowo Mizuno; Shigeatsu Fujiki; Tatsuya Toyokawa; Yuko Okamoto; Toshihiro Murata; Yoshinari Kawai; Daisuke Tanioka; Hiroyuki Okada; Kazuhide Yamamoto


European Journal of Gastroenterology & Hepatology | 2008

Clinical factors that impair health-related quality of life in ulcerative colitis patients vary with the disease duration

Motoaki Kuriyama; Jun Kato; Kenji Kuwaki; Naofumi Morimoto; Toru Nawa; Tsuyoshi Fujimoto; Hiroyuki Kono; Nobuaki Okano; Jiro Miyaike; Takechiyo Morita; Hiroyuki Okada; Seiyuu Suzuki; Toshifumi Yoshioka; Junji Shiode; Kinichiro Suwaki; Kohsaku Sakaguchi; Yasushi Shiratori


Hepato-gastroenterology | 2007

Identification of risk factors for lymph node metastasis of colorectal cancer.

Satoshi Takano; Jun Kato; Hiroshi Yamamoto; Junji Shiode; Junichirou Nasu; Hirofumi Kawamoto; Hiroyuki Okada; Yasushi Shiratori


Hepato-gastroenterology | 2007

Risk Factors and Indications for First Surgery in Crohn's Disease Patients

Naofumi Morimoto; Jun Kato; Motoaki Kuriyama; Tsuyoshi Fujimoto; Junichirou Nasu; Jiro Miyaike; Takechiyo Morita; Hiroyuki Okada; Seiyuu Suzuki; Junji Shiode; Hiroshi Yamamoto; Kohsaku Sakaguchi; Yasushi Shiratori


Oncology Letters | 2015

A multicenter survey of enteroscopy for the diagnosis of intestinal follicular lymphoma

Masaya Iwamuro; Hiroyuki Okada; Seiji Kawano; Junji Shiode; Ryuta Takenaka; Atsushi Imagawa; Tomoki Inaba; Seiyu Suzuki; Mamoru Nishimura; Motowo Mizuno; Masashi Araki; Tomohiko Mannami; Toru Ueki; Haruhiko Kobashi; Haruka Fukatsu; Shouichi Tanaka; Akiyoshi Omoto; Yoshinari Kawai; Takashi Kitagawa; Tatsuya Toyokawa; Katsuyoshi Takata; Tadashi Yoshino; Akinobu Takaki; Kazuhide Yamamoto


Internal Medicine | 2013

Diagnosis of a solid pseudopapillary neoplasm using EUS-FNA.

Masakuni Fujii; Hiroaki Saito; Hironari Kato; Toru Kojima; Mamoru Ito; Shuhei Ishiyama; Akiko Fujiwara; Takefumi Niguma; Masao Yoshioka; Junji Shiode; Tetsushige Mimura; Kazuhide Yamamoto

Collaboration


Dive into the Junji Shiode's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Seiyuu Suzuki

Shiga University of Medical Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge